Interstitial Lung Disease Treatment in Pittsburgh

The Lung Institute is coming to PA

The Lung Institute specializes in treating debilitating lung diseases like interstitial lung disease using cellular therapy. Interstitial lung disease is an umbrella term used to categorize over 100 different types of pulmonary disorders that affect the absorption of oxygen into the lungs. It includes a diverse collection of illnesses with a variety of causes, treatments and prognoses. Individuals who suffer from interstitial lung disease often have difficulty breathing and moving from place to place due to a consistent feeling of shortness of breath. Disorders classified under interstitial lung disease are often characterized by scarring of the lung’s delicate tissues and a dry, pestering cough.

Many interstitial lung disease sufferers have experienced an improved quality of live after undergoing cellular therapy. One Lung Institute patient, Arnold M., reported on a recent trip to his pulmonologist. “The pulmonologist said, ‘You seem to be doing real well, what have you been doing lately?’ I said that I’ve just been taking care of myself and he goes ‘My god, you’ve been doing a good job.’ He couldn’t believe I was that good. So, I walked up and down the hall for him and he said, ‘My god you are doing good.’ Then I told him about cells and he stood there with his mouth hanging open. I guess he didn’t run across anybody that has done it. He was kind of amazed.”

Cellular Therapy

So how does the process work? The minimally invasive outpatient procedure typically takes three days. The cells are extracted from the patient’s blood, fat or bone marrow, treated, and then reintroduced into the body. Cells naturally act as our body’s system to promote healing, so by reintroducing them into the body directly into the areas that need it, we’re essentially speeding up the body’s natural healing process. When we use cells from our own bodies, we also eliminate the possibility of the body rejecting the cells.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomat of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Dr. Coleman and the Lung Institute look forward to being able to treat more patients by opening a fourth clinic in Pittsburgh. The clinic will open July 13, 2015 and the ribbon cutting ceremony will be attended by medical staff, the Lung Institute’s corporate team members and local Pittsburgh Chamber of Commerce Members.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if cellular therapy can help get your life back within reach. Contact us by calling (800) 729-3065 to see if you qualify.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.